Day One Announces Two New Appointments to Board of Directors
BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage...
Pharmaceutical
Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme
BASKING RIDGE, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis
Up to 40% of women with triple negative breast cancer (TNBC) experience metastasis to their brain, which affects physical function,...
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the...
Mary Beth DeLena Joins PepGen as General Counsel and Secretary
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Financing was led by New Enterprise Associates (NEA) and closed with additional new investor Atlas Venture and continued investment by...
MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Samsung Bioepis Releases First Quarter 2024 US Biosimilar Market Report
Report highlights latest biosimilar pricing and market share status, including state of the adalimumab marketBiosimilar Deep Dive section illustrates patient...
Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd
The Combined Company Is Expected To Trade On Nasdaq Post-Closing Under A New Ticker SymbolMediforum is a leading biotechnology company...
Arvinas Appoints Jared Freedberg as General Counsel
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4)NEW HAVEN, Conn., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company...
PrestoDoctor Expands Its Cannabis Telemedicine Service to West Virginia
MESQUITE, NV / ACCESSWIRE / January 17, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated...
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Market opportunity estimated to be greater than US$1...
PMD – New Name and Ticker Symbol; Irish Minister to Attend Bell-Ringing Ceremony
STOCKHOLM, SWEDEN / ACCESSWIRE / January 16, 2024 / Promore Pharma (STO:PROMO) (FRA:8T0) Following the reverse acquisition of Promore Pharma...
Manatt Expands National Health Care Offerings With Leading Health Policy Strategist in D.C.
Heide Bajnrauh applies her extensive background across policy, reimbursement and coding to guide clients through various challenges and opportunities by...
Model N Announces Date of First Quarter Fiscal Year 2024 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, plans to announce financial results...
The Orthobiologic Institute and ZetrOZ Systems Launch 2024 Clinical Education Program on Non-Opioid and Non-Surgical Soft-Tissue Regenerative Techniques for Clinicians
Clinical education director Dr. Rajiv Mallipudi will present on sam® research and treatment protocols in a program for members of...
PMD Updates on the Reverse Share Split Following the Reverse Acquisition
STOCKHOLM, SWEDEN / ACCESSWIRE / January 16, 2024 / Promore Pharma (STO:PROMO)(FRA:8T0) PMD Device Solutions AB ("PMD" or the "Company")...
Gilead Sciences with Emma’s Story: Self-Advocacy in Breast Cancer
NORTHAMPTON, MA / ACCESSWIRE / January 16, 2024 / "It's an experience that I hope no one goes through, but...
TOUCHBBCA Joins the Carebox Connect Network
When We Tri(al) by TOUCH, The Black Breast Cancer Alliance has partnered with Carebox to provide Breasties, caregivers, and the...